Roble, Belko & Company, Inc GSK PLC Transaction History
Roble, Belko & Company, Inc
- $634 Million
- Q3 2024
Number of Shares
685
Previous 2,845
75.92%
Holding current value
$28,000
Previous $110,000
74.55%
% of portfolio
0.0%
Previous 0.02%